[{"id":"da225a45-4246-4e90-a4b5-d01c0f7dff7e","acronym":"","url":"https://clinicaltrials.gov/study/NCT04835519","created_at":"2021-04-08T13:52:32.724Z","updated_at":"2024-07-02T16:35:56.172Z","phase":"Phase 1/2","brief_title":"Phase I/II Study of Enhanced CD33 CAR T Cells in Subjects With Relapsed or Refractory Acute Myeloid Leukemia","source_id_and_acronym":"NCT04835519","lead_sponsor":"Beijing Boren Hospital","biomarkers":" CD33","pipe":" | ","alterations":" CD33 positive","tags":["CD33"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD33 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • CD33 CAR T cells"],"overall_status":"Recruiting","enrollment":" Enrollment 25","initiation":"Initiation: 04/08/2021","start_date":" 04/08/2021","primary_txt":" Primary completion: 09/08/2024","primary_completion_date":" 09/08/2024","study_txt":" Completion: 09/08/2024","study_completion_date":" 09/08/2024","last_update_posted":"2023-02-08"}]